In the study of acute lymphocytic leukemia (ALL), PUMA induced by some dual mTOR inhibitors is a major determinant in killing ALL cells, via mTORC1/4EBP1/MYC/PUMA pathway16. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.